Apellis Pharmaceuticals, Inc. - Common Stock, $0.0001 par value (APLS)

CUSIP: 03753U106

Q1 2023 13F Holders as of 31 Mar 2023

Type / Class
Equity / Common Stock, $0.0001 par value
Shares outstanding
125,684,656
Total 13F shares
110,363,167
Share change
+9,828,707
Total reported value
$7,278,027,538
Put/Call ratio
65%
Price per share
$65.96
Number of holders
277
Value change
+$671,099,429
Number of buys
167
Number of sells
102

Quarterly Holders Quick Answers

What is CUSIP 03753U106?
CUSIP 03753U106 identifies APLS - Apellis Pharmaceuticals, Inc. - Common Stock, $0.0001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Apellis Pharmaceuticals, Inc. - Common Stock, $0.0001 par value (APLS) as of Q1 2023

As of 31 Mar 2023, Apellis Pharmaceuticals, Inc. - Common Stock, $0.0001 par value (APLS) was held by 277 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 110,363,167 shares. The largest 10 holders included Avoro Capital Advisors LLC, VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., T. Rowe Price Investment Management, Inc., EcoR1 Capital, LLC, JANUS HENDERSON GROUP PLC, PRICE T ROWE ASSOCIATES INC /MD/, Octagon Capital Advisors LP, and STATE STREET CORP. This page lists 278 institutional shareholders reporting positions in this security for the Q1 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.